Wellness and performance
Immune & defense
Thymulin
Thymulin is a zinc-dependent thymic peptide tied to immune-cell development. See how it works, what the research shows, and where it stands with the FDA.
- Reviewed by
- William Maish, MD MBA MPH, Clinical Product Lead
- Published
- October 5, 2026
- Last updated
- October 5, 2026
Key takeaway
Thymulin is a zinc-dependent thymic peptide involved in immune-cell development, sold on the "research peptide" market for immune support. Its biology is well described, but there is essentially no interventional human evidence for the administered peptide. As of 2026 it is not FDA-approved.
At a glance
| FDA status | Not FDA-approved, sold in the wellness/gray market |
| What it is | Thymic immune hormone, biologically active only when bound to zinc |
| Research | Endogenous biology well studied, but no modern trials of giving it as a therapy |
| Global approval | Not approved anywhere as a treatment |
| Evidence strength | Low research |
What is thymulin?
Thymulin is a nine-amino acid peptide produced by the thymus gland, where immune cells mature. It is unusual in that it is only biologically active when coupled to zinc. It has historically been studied as a thymic immune hormone, and it is sold through wellness and "research peptide" channels for immune support. It is not an approved medicine.
How does it work?
Thymulin is involved in the development and differentiation of T-cells, the immune system's coordinating cells, and has been reported in animal work to have anti-inflammatory and pain-modulating effects. A notable feature of its biology is the zinc link: zinc deficiency lowers active thymulin levels and shifts the immune response. These mechanisms come largely from animal and physiological studies. This describes the proposed mechanism, separate from demonstrated benefit from giving the peptide.
Is it FDA-approved?
No. Thymulin is not approved by the FDA or any regulator as a therapy. It is not on FDA compounding lists and was not among the peptides reviewed at the 2026 FDA compounding advisory meetings.
What does the research show?
The evidence is largely preclinical and physiological. According to PubMed, the main human-relevant observations are that thymulin activity tracks zinc status and thymic function, summarized in reviews1 of its biology and of zinc and immunity2. There are no modern controlled trials of administered thymulin for any wellness or immune use, so its marketed benefit is unestablished.
More for immune & defense
Sources: a review of thymulin biology (Reggiani et al., Annals of the New York Academy of Sciences, 2009, DOI: 10.1111/j.1749-6632.2008.03964.x1) and a review of zinc, thymulin, and immunity (Prasad, Journal of Nutrition, 2007, DOI: 10.1093/jn/137.5.13452), indexed on PubMed. This document is educational, is not medical advice or a health claim, and is not an offer to sell any product.